VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Getting it over the finish line was a labor of love—and now, more than five years after her death, the lab of former Sloan ...

Most people on Earth are habitats for mites that spend the majority of their brief lives burrowed, head-first, in our hair ...

With the help of Pokémon or Bad Gyal–style looks, a handful of women communicators explain science on social media as they ...

A study led by researchers at the Institute for Bioengineering of Catalonia (IBEC), in collaboration with the Proteomics ...

But research suggests that there may be another important factor: genetics.  Professor Shannon Kelleher of the Biomedical and Nutritional Sciences Department is partnering with Associate Professor ...

Researchers at the Icahn School of Medicine at Mount Sinai have found that patients with Parkinson's disease undergoing deep ...

At the Annual General Meeting of ABL Diagnostics (Paris:ABLD) held on Tuesday, June 30, 2026, at 11:00 a.m., shareholders approved all resolutions submitted for their vote, including ...

Synthetic SpudCell, built from chemicals alone, grew, divided, and evolved naturally - a milestone in creating programmable ...

Obesity could be associated with a distinct molecular process driving the transition from an early-stage, premalignant breast ...

A defense system that cannot distinguish friend from stranger eventually harms the organization it is supposed to protect.

ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...